Orzechowski Anthony, Petrides Victoria, Scopp Richard
Abbott, Abbott Park, IL, USA.
Clin Biochem. 2018 Jul;57:48-55. doi: 10.1016/j.clinbiochem.2018.04.012. Epub 2018 Apr 17.
To design and deliver high quality, safe and effective products, manufacturers of in vitro diagnostic (IVD) products follow a structured, traceable process for controlling the uncertainty of results reported from their measurement systems. This process and its results however, are not often shared in detail with those outside of the manufacturing company. The objective of this paper is to facilitate discussion by describing some of the best practices used during the IVD design and development process, highlighting some design challenges manufacturers face, and to offer ideas for how IVD manufacturers and laboratories could work together to drive further improvement to public health.
为了设计和交付高质量、安全且有效的产品,体外诊断(IVD)产品制造商遵循一个结构化、可追溯的过程来控制其测量系统报告结果的不确定性。然而,这个过程及其结果通常不会详细地与制造公司以外的人分享。本文的目的是通过描述IVD设计和开发过程中使用的一些最佳实践、强调制造商面临的一些设计挑战,并就IVD制造商和实验室如何共同努力推动公共卫生的进一步改善提供思路,来促进讨论。